🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the efficacy and safety of 2 doses ...
Status
Active Not Recruiting
Location
Childrens Healthcare of Atlanta
Start Date
2019-07-26
Trial ID
NCT03814746
Treatments Being Tested
This is a Phase 2 trial that will test the efficacy and safety of crizanliz...
Status
Completed
Location
Andria Ford
Start Date
2021-01-25
Trial ID
NCT04611880
Treatments Being Tested
This was a retrospective descriptive analysis of health care claims data us...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-08-30
Trial ID
NCT05494541
Treatments Being Tested
This is a randomized, open label, adaptive platform trial to compare the ef...
Status
Completed
Location
University of Alabama
Start Date
2020-09-04
Trial ID
NCT04505774
Treatments Being Tested
This is a multi-center multi-national rollover study to allow continued acc...
Status
Recruiting
Location
University Of Alabama
Start Date
2021-06-10
Trial ID
NCT04657822
Treatments Being Tested
The purpose of this study was to confirm and to establish appropriate dosin...
Status
Completed
Location
University Of Alabama
Start Date
2018-10-01
Trial ID
NCT03474965
Treatments Being Tested
The purpose of this study was to investigate the safety, pharmacokinetics a...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2019-09-26
Trial ID
NCT04097821
Treatments Being Tested
In this prospective, single-arm, open-label, imaging and treatment study, t...
Status
Unknown
Location
Barnes-Jewish Hospital
Start Date
2022-08-01
Trial ID
NCT05334576
Treatments Being Tested
The purpose of this registration is to list Managed Access Programs (MAPs) ...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT03720626
Treatments Being Tested
Sickle cell disease (SCD) is a genetic blood disorder. Crizanlizumab is ind...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-07-14
Trial ID
NCT04662931
Treatments Being Tested